Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Piloting Focal Therapy in Prostate Cancer

Imaging is essential at many decision points in the management of localized prostate cancer with focal therapy. These decisions include patient selection, choice of focal therapy, assessment of treatment efficacy, and potential need for focal retreatment or radical therapy.

Tay and colleagues[4] from Singapore General Hospital and the National Cancer Center in Singapore investigated the safety profile and 2-year functional outcomes of in-bore magnetic resonance (MR)-guided focused ultrasound therapy in 14 men with low-volume, low-grade prostate cancer, with up to two primary foci (clinical stage T2a or lower, Gleason score 3+3, index tumor ≤ 10 mm3).

Read more.

source: Medscape